CAN B-LYMPHOCYTE STIMULATOR (BLYS) BE A SEROLOGICAL PROGNOSTIC MARKER IN PATIENTS WITH NEUROENDOCRINE TUMORS?
AACE ePoster Library. Grimaldi F. 05/27/16; 131405; 844
Prof. Dr. Franco Grimaldi
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}